ADAMTS13 and thrombotic thrombocytopenic purpura: Additional research needs to be aimed at this population to investigate if the threshold to trigger an episode of immune TTP is lowered, as well as a propensity for relapse and recurrent episodes in the setting of decreased baseline ADAMTS13 activity and antigen levels.